Journal of Acute Care

Register      Login

VOLUME 2 , ISSUE 2 ( May-August, 2023 ) > List of Articles


“Renal Replacement” to “Renal to Support” Therapy: A Narrative Review

Ranajit Chatterjee, Rajesh C Mishra, Ahsina J Lopa

Keywords : Acute renal failure, Kidney, Nephritis, Renal replacement, Renal replacement therapy, Acute kidney, Renal

Citation Information : Chatterjee R, Mishra RC, Lopa AJ. “Renal Replacement” to “Renal to Support” Therapy: A Narrative Review. 2023; 2 (2):61-64.

DOI: 10.5005/jp-journals-10089-0055

License: CC BY-NC 4.0

Published Online: 30-10-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Critically ill patients had been suffering form kidney injuires since time immemorial. Scientists and doctors coined different names through ages without fully understanding the pathophysiology and nature of injuries. It was coined as ‘Acute Bright's disease’ in the early twentieth century, ‘War Nephritis’ during the first world war only to be coined as acute renal failure in the mid 20th century. Acute kidney injury is a relatively new terminology coined in this century. As the understanding of the nature of the disease become clearer, newer modalities of treatment started evolving. Renal replacement therapy is one such modality. Again with experience, doctors found that this form of therapy is not only restricted in replacing the kidney function but also can be extended much beyond the boundaries of renal dysfunction. Thus, the term ‘Renal support’ instead of ‘Renal Replacement’ came into vogue. This narrative review will try to explore the variety of support the therapy gives to a critically ill patient.

  1. Peitzman SJ. Chronic Renal Disease. Elsevier; 2020.
  2. Keith NM, Thomson WWD. War nephritis: a clinical, functional, and pathological study. QJM: Int J Med 1918;11(43):229–266. DOI: 10.1093/qjmed/os-11.43.229
  3. Tiwari SC, Bhowmik DM, Dash SC. Is the term ‘renal support therapy’ more appropriate than ‘renal replacement therapy’? Nephrol Dial Transplant 2005;20(8):1770–1771. DOI: 10.1093/ndt/gfh931
  4. Alvarez G, Chrusch C, Hulme T, et al. Renal replacement therapy: a practical update. Can J Anesth 2019;66(5):593–604. DOI: 10.1007/s12630-019-01306-x
  5. Tandukar S, Palevsky PM. Continuous renal replacement therapy: who, when, why, and how. Chest 2019;155(3):626–638. DOI: 10.1016/j.chest.2018.09.004
  6. Wei SS, Lee WT, Woo KT. Slow continuous ultrafiltration (SCUF)—the safe and efficient treatment for patients with cardiac failure and fluid overload. Singapore Med J 1995;36(3):276–277. PMID: 8553091.
  7. Hanafusa N. Application of continuous renal replacement therapy: what should we consider based on existing evidence? Blood Purif 2015;40(4):312–319. DOI: 10.1159/000441579
  8. Pannu N, Gibney RN. Renal replacement therapy in the intensive care unit. Ther Clin Risk Manag 2005;1(2):141–150. DOI: 10.2147/tcrm.
  9. Hellman T, Uusalo P, Järvisalo MJ. Renal replacement techniques in septic shock. Int J Mol Sci 2021;22(19):10238. DOI: 10.3390/ijms221910238
  10. Katwal S, Malbul K, Mandal SK, et al. Successfully managed aluminum phosphide poisoning: a case report. Ann Med Surg (Lond) 2021;70:102868. DOI: 10.1016/j.amsu.2021.102868
  11. Kidney Disease Outcomes Quality Initiative KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int Suppl. 2012; 2:1–138. Published online 2015 Apr 6.
  12. Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 2016;315(20):2190–2199. DOI: 10.1001/jama.2016.5828
  13. Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 2016;375(2):122–133. DOI: 10.1056/NEJMoa1603017
  14. Barbar SD, Clere-Jehl R, Bourredjem A, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 2018;379(15):1431–1442. DOI: 10.1056/NEJMoa1803213
  15. The STARRT-AKI Investigators, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, et al. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 2020;383(3):240–251. DOI: 10.1056/nejmoa2000741
  16. Gaudry S, Hajage D, Martin-Lefevre L, et al. The artificial kidney initiation in kidney injury 2 (AKIKI2): study protocol for a randomized controlled trial. Trials 2019;20(1):726. DOI: 10.1186/s13063-019-3774-9
  17. Prowle JR, Schneider A, Bellomo R. Clinical review: optimal dose of continuous renal replacement therapy in acute kidney injury. Crit Care 2011;15(2):207. DOI: 10.1186/cc9415
  18. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359(1):7–20. DOI: 10.1056/NEJMoa0802639
  19. Vijayan A, Palevsky PM. Dosing of renal replacement therapy in acute kidney injury. Am J Kidney Dis 2012;59(4):569–576. DOI: 10.1053/j.ajkd.2011.11.035
  20. Vásquez Jiménez E, Anumudu SJ, Neyra JA. Dose of continuous renal replacement therapy in critically ill patients: a bona fide quality indicator. Nephron 2021;145(2):91–98. DOI: 10.1159/000512846
  21. Viallet N, Brunot V, Kuster N, et al. Daily urinary creatinine predicts the weaning of renal replacement therapy in ICU acute kidney injury patients. Ann Intensive Care 2016;6(1):71. DOI: 10.1186/s13613-016-0176-y
  22. Honoré PM, De Waele E, Jacobs R, et al. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif 2013;35(4):279–284. DOI: 10.1159/000350610
  23. Fahimi F, Emami S, Rashid Farokhi F. The rate of antibiotic dosage adjustment in renal dysfunction. Iran J Pharm Res 2012;11(1):157–161. PMCID: PMC3813091.
  24. Hoff BM, Maker JH, Dager WE, et al. Antibiotic dosing for critically ill adult patients receiving intermittent hemodialysis, prolonged intermittent renal replacement therapy, and continuous renal replacement therapy: an update. Ann Pharmacother 2020;54(1):43–55. DOI: 10.1177/1060028019865873
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.